COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in
Algeria: National Cross-Sectional Survey-Based Study

J 2022

COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study

LOUNIS, M., D. BENCHERIT, M. A. RAIS a Abanoub RIAD

Základní údaje

Originální název

COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study

Autoři

LOUNIS, M., D. BENCHERIT, M. A. RAIS a Abanoub RIAD (818 Egypt, garant, domácí)

Vydání

Vaccines, Basel, MDPI, 2022, 2076-393X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 7.800

Kód RIV

RIV/00216224:14110/22:00125707

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.3390/vaccines10040621

UT WoS

000787033200001

Klíčová slova anglicky

COVID-19; vaccine; vaccine booster; vaccine hesitancy; vaccine acceptance; Algeria

Štítky

14110525, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 19. 7. 2022 09:18, Mgr. Tereza Miškechová

Anotace

V originále

Due to the emergence of various highly contagious variants of SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This strategy has, however, posed another challenge for the national authorities to convince their population to receive the booster after the first challenge of COVID-19 primer dose vaccines. This study was conducted to determine COVID-19 vaccine booster acceptance and its associated factors in the general population in Algeria. Using social media platforms, an online self-administered questionnaire was distributed between 28 January and 5 March 2022 for all Algerian citizens who received COVID-19 vaccines. Overall, 787 respondents were included in this study. Among them, 51.6%, 25%, and 23.8% accepted, rejected, or were hesitant about the COVID-19 vaccine booster, respectively. However, only 13.2% declared receiving the booster dose. Additionally, while 58.2% of the respondents declared being relieved after primer vaccination, 11.4% among them declared that they regretted being vaccinated. The most common reasons for acceptance were experts’ recommendations (24.6%) and the belief that COVID-19 vaccine boosters were necessary and efficient, while rejection was mainly due to the belief that primer doses are sufficient (15.5%), or that vaccination in general is inefficient (8%). Males, older individuals, those with chronic comorbidities or a history of COVID-19 infection, non-healthcare workers, and those with low educational levels were associated with significantly higher odds for booster acceptance. Moreover, belief that booster doses were necessary and efficient, disagreeing with the notion that primer doses were not sufficient, experts’ recommendations, and the desire to travel abroad were significantly associated with higher odds of COVID-19 vaccine booster acceptance.

Citovat

LOUNIS, M., D. BENCHERIT, M. A. RAIS a Abanoub RIAD. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study. Vaccines. Basel: MDPI, 2022, roč. 10, č. 4, s. 1-14. ISSN 2076-393X. Dostupné z: https://dx.doi.org/10.3390/vaccines10040621.

@article{1849258,
   author = {Lounis, M. and Bencherit, D. and Rais, M. A. and Riad, Abanoub},
   article_location = {Basel},
   article_number = {4},
   doi = {http://dx.doi.org/10.3390/vaccines10040621},
   keywords = {COVID-19; vaccine; vaccine booster; vaccine hesitancy; vaccine acceptance; Algeria},
   language = {eng},
   issn = {2076-393X},
   journal = {Vaccines},
   title = {COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study},
   url = {https://www.mdpi.com/2076-393X/10/4/621},
   volume = {10},
   year = {2022}
}

TY  - JOUR
ID  - 1849258
AU  - Lounis, M. - Bencherit, D. - Rais, M. A. - Riad, Abanoub
PY  - 2022
TI  - COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study
JF  - Vaccines
VL  - 10
IS  - 4
SP  - 1-14
EP  - 1-14
PB  - MDPI
SN  - 2076393X
KW  - COVID-19
KW  - vaccine
KW  - vaccine booster
KW  - vaccine hesitancy
KW  - vaccine acceptance
KW  - Algeria
UR  - https://www.mdpi.com/2076-393X/10/4/621
N2  - Due to the emergence of various highly contagious variants of SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This strategy has, however, posed another challenge for the national authorities to convince their population to receive the booster after the first challenge of COVID-19 primer dose vaccines. This study was conducted to determine COVID-19 vaccine booster acceptance and its associated factors in the general population in Algeria. Using social media platforms, an online self-administered questionnaire was distributed between 28 January and 5 March 2022 for all Algerian citizens who received COVID-19 vaccines. Overall, 787 respondents were included in this study. Among them, 51.6%, 25%, and 23.8% accepted, rejected, or were hesitant about the COVID-19 vaccine booster, respectively. However, only 13.2% declared receiving the booster dose. Additionally, while 58.2% of the respondents declared being relieved after primer vaccination, 11.4% among them declared that they regretted being vaccinated. The most common reasons for acceptance were experts’ recommendations (24.6%) and the belief that COVID-19 vaccine boosters were necessary and efficient, while rejection was mainly due to the belief that primer doses are sufficient (15.5%), or that vaccination in general is inefficient (8%). Males, older individuals, those with chronic comorbidities or a history of COVID-19 infection, non-healthcare workers, and those with low educational levels were associated with significantly higher odds for booster acceptance. Moreover, belief that booster doses were necessary and efficient, disagreeing with the notion that primer doses were not sufficient, experts’ recommendations, and the desire to travel abroad were significantly associated with higher odds of COVID-19 vaccine booster acceptance.
ER  -

LOUNIS, M., D. BENCHERIT, M. A. RAIS a Abanoub RIAD. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study. \textit{Vaccines}. Basel: MDPI, 2022, roč.~10, č.~4, s.~1-14. ISSN~2076-393X. Dostupné z: https://dx.doi.org/10.3390/vaccines10040621.

Podrobný výpis o publikaci